SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CCS

目标：本次采购的目标是继续开展“调查 已被测试致癌活性的化合物”（通常 PHS-149）。1995-1998. 该文件规定，在 准备参考的形式，一个浓缩的世界文学， 致癌性测试 它补充了IARC关于 人类致癌风险评估及IARC信息 致癌性试验化学品调查公报 NCI/NTP技术报告系列。 PHS-149仍然是一个 不仅对联邦和州卫生和监管部门 也适用于从事临床致癌作用的研究人员 research.除了在国内发行外，还向 用户遍布33个国家。 PHS-149的价值得到了 对1993年进行的用户调查的答复，以及 从本文件用户收到的未经请求的答复。 所有 反应热烈，赞成继续这一努力。 按照以往的做法，这些文件将由 政府印刷局。 NCI将继续向 联邦和州政府机构、学术界和感兴趣的研究人员， 美国和海外，和文件的监督将被要求 向公众销售PHS-149。

Objectives: The objective of this procurement is to continue the "Survey of Compounds Which Have Been Tested for Carcinogenic Activity" (commonly known as PHS-149) for the year. 1995-1998. The document provides, in ready reference form, a condensation of the world literature on carcinogenicity testing. It augments the IARC Monographs on the Evaluation of Carcinogenic Risks to Humans and the IARC Information Bulletin on the Survey of Chemicals Being Tested for Carcinogenicity, as well as the NCI/NTP Technical Report Series. PHS-149 still serves as a valuable resource not only to Federal and state health and regulatory agencies but also to investigators engaged in clinical carcinogenesis research. In addition to domestic distribution, copies are distributed to users in over 33 foreign countries. The value of PHS-149 was confirmed by the responses to a user survey conducted in 1993, and the numerous unsolicitated responses received from users of this document. All responses have been enthusiastic in favor of continuing this effort. As has been the practice in the past, the documents will be published by the Government Printing Office. NCI will continue to make distribution to Federal and state agencies, academia and interested researchers both in the U.S. and overseas, and the Superintendent of Documents will be asked to put PHS-149 on sale for the general public.